Financial reports
20-F
2022 FY
Annual report (foreign)
6 Apr 23
20-F
2021 FY
Annual report (foreign)
28 Apr 22
20-F
2020 FY
Annual report (foreign)
20 Apr 21
20-F
2019 FY
Annual report (foreign)
16 Apr 20
20-F
2018 FY
Annual report (foreign)
30 Apr 19
20-F
2017 FY
Annual report (foreign)
15 May 18
NT 20-F
Notice of late annual filing (foreign)
1 May 18
20-F
2016 FY
Annual report (foreign)
27 Apr 17
20-F
2015 FY
Annual report (foreign)
31 Mar 16
20-F
2014 FY
Annual report (foreign)
14 Apr 15
Current reports
6-K
Current report (foreign)
5 Dec 23
6-K
Medicure Announces Fda Provides Complete Approval to Enroll Patients In Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
24 Nov 23
6-K
Current report (foreign)
21 Nov 23
6-K
Current report (foreign)
5 Sep 23
6-K
Current report (foreign)
24 Jul 23
6-K
Current report (foreign)
31 May 23
6-K
Medicure Announces Resignation of Board Member and Grant of Stock Options
1 Feb 23
6-K
Current report (foreign)
25 Nov 22
6-K
Condensed Consolidated Interim Financial Statements
23 Nov 22
6-K
Current report (foreign)
17 Nov 22
Registration and prospectus
F-X
Appointment of agent for service of process by issuers registering securities
14 Nov 19
25
Voluntary exchange delisting
3 Jul 08
S-8
Registration of securities for employees
9 Oct 07
REGDEX
Notice of sale of securities
5 Jan 07
F-10/A
Registration of securities (Canada) (amended)
5 Jan 07
F-10/A
Registration of securities (Canada) (amended)
3 Jan 07
F-10
Registration of securities (Canada)
29 Dec 06
F-X
Appointment of agent for service of process by issuers registering securities
29 Dec 06
F-10/A
Registration of securities (Canada) (amended)
24 May 06
F-10
Registration of securities (Canada)
15 May 06
Proxies
No filings